Trials / Unknown
UnknownNCT02786017
Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis
The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Decompensated Cirrhosis
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of injectable collagen scaffold combined with human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) transplantation in patients with Decompensated Cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Conventional therapy | Patients will receive the conventional therapy. |
| BIOLOGICAL | Injectable Collagen Scaffold + HUC-MSCs | Injectable collagen scaffold combined with HUC-MSCs was injected into left lateral segment, left medial segment, right anterior segment, right posterior segment and caudate lobe under B-mode ultrasound supervision, respectively. The total amount of HUC-MSCs was 5\*10\^8. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2016-05-30
- Last updated
- 2020-01-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02786017. Inclusion in this directory is not an endorsement.